Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
Abstract Background Nanoscale drug delivery systems have emerged as broadly applicable approach for chemo-photothermal therapy. However, these nanoscale drug delivery systems suffer from carrier-induced toxicity, uncontrolled drug release and low drug carrying capacity issues. Thus, to develop carri...
Main Authors: | Mingtao Ao, Fei Yu, Yixiang Li, Mengya Zhong, Yonghe Tang, Hua Yang, Xiaojing Wu, Yifan Zhuang, Huiyun Wang, Xiaolian Sun, Xuehui Hong, Xiao Dong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-01093-y |
Similar Items
-
Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy
by: Zhaopei Guo, et al.
Published: (2022-10-01) -
Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug
by: Wenhua Li, et al.
Published: (2021-01-01) -
Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy
by: Zhang, Yuanyuan, et al.
Published: (2020) -
Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs
by: Mo Zhou, et al.
Published: (2014-11-01) -
Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs
by: Dinghua Liang, et al.
Published: (2018-08-01)